Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Pharma deals during January 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

The game changer: Gaming in healthcare

How gaming can affect health, from improving lifestyle habits and behaviour modification, to self-management, through to motivating and supporting physical activity

Quintiles to go public

Predicts pharma's outsourced research spend will continue to grow

- PMLiVE

OncoAssist becomes latest app to be classified as a medical device

Cancer iPhone and iPad app offers clinical decision support tools

Sanofi reception

FDA to review Sanofi’s lixisenatide for diabetes

Follows drug's European approval under brand name Lyxumia earlier this month

Roche - Basel

Roche licenses Chiasma’s acromegaly drug in $595m deal

Alternative to injection for hormonal disorder

- PMLiVE

AZ in atherosclerosis education drive during US Heart Month

Encouraging the public to learn more about the causes of heart disease

- PMLiVE

Phytopharm shares dive as Parkinson’s drug fails

Stock falls 80 per cent after Cogane failure in phase II

- PMLiVE

Ironwood promotes Dr Mark Currie

He moves up to chief scientific officer at the US pharma company

- PMLiVE

BMS hires Shire’s Ann Powell Judge to head human resources

She has also served at Wyeth and the Dow Chemical Company

- PMLiVE

NICE recommends test to support choice of breast cancer treatment

Genomic Health’s Oncotype DX could avoid over-treatment using chemotherapy

- PMLiVE

15 years since the first paper published on RNA interference

This month in 1998: Andrew Fire and Craig Mello's breakthrough paper

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links